Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Puig

Showing results (21-30 of 423) with videos related to

Pageof 43
Sort By:
Actas Dermo-Sifiliograficas|October 1, 2023
[Translated article] Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classification in DermatologyL Puig
Journal of the European Academy of Dermatology and Venereology : JEADV|November 13, 2014
Biosimilars in psoriasis 2015: what is next?L Puig
Actas Dermo-Sifiliograficas|October 8, 2013
Biosimilars and reference biologics: decisions on biosimilar interchangeability require the involvement of dermatologistsL Puig
Actas Dermo-Sifiliograficas|October 14, 2020
Meta-analysis and Indirect Comparisons: on Methods, Paradigms, and Biologic Treatments for PsoriasisL Puig
Journal of the European Academy of Dermatology and Venereology : JEADV|April 16, 2011
Obesity and psoriasis: body weight and body mass index influence the response to biological treatmentL Puig
The British Journal of Dermatology|September 24, 2017
Choice of first-line biologic therapy in psoriasis: understanding the past and shaping the future?L Puig
Actas Dermo-Sifiliograficas|February 23, 2019
Incremental Cost per Responder (PASI-75, PASI-90 and PASI-100) Based on a Network Meta-Analysis of Biologic Therapies for Psoriasis: Spain 2018L Puig
Actas Dermo-Sifiliograficas|December 11, 2012
Biosimilars in dermatology: starting with infliximabL Puig
The British Journal of Dermatology|April 26, 2013
Anti-tumour necrosis factor-α treatment and weight gain in psoriasis: the 'pudgy blanching' conundrumL Puig
Actas Dermo-Sifiliograficas|May 18, 2012
Cardiovascular Risk and Psoriasis: the Role of Biologic TherapyL Puig
Pageof 43

Showing results (21-30 of 423) with videos related to

Sort By:
Pageof 43
Actas Dermo-Sifiliograficas|October 1, 2023
[Translated article] Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classification in DermatologyL Puig
Journal of the European Academy of Dermatology and Venereology : JEADV|November 13, 2014
Biosimilars in psoriasis 2015: what is next?L Puig
Actas Dermo-Sifiliograficas|October 8, 2013
Biosimilars and reference biologics: decisions on biosimilar interchangeability require the involvement of dermatologistsL Puig
Actas Dermo-Sifiliograficas|October 14, 2020
Meta-analysis and Indirect Comparisons: on Methods, Paradigms, and Biologic Treatments for PsoriasisL Puig
Journal of the European Academy of Dermatology and Venereology : JEADV|April 16, 2011
Obesity and psoriasis: body weight and body mass index influence the response to biological treatmentL Puig
The British Journal of Dermatology|September 24, 2017
Choice of first-line biologic therapy in psoriasis: understanding the past and shaping the future?L Puig
Actas Dermo-Sifiliograficas|February 23, 2019
Incremental Cost per Responder (PASI-75, PASI-90 and PASI-100) Based on a Network Meta-Analysis of Biologic Therapies for Psoriasis: Spain 2018L Puig
Actas Dermo-Sifiliograficas|December 11, 2012
Biosimilars in dermatology: starting with infliximabL Puig
The British Journal of Dermatology|April 26, 2013
Anti-tumour necrosis factor-α treatment and weight gain in psoriasis: the 'pudgy blanching' conundrumL Puig
Actas Dermo-Sifiliograficas|May 18, 2012
Cardiovascular Risk and Psoriasis: the Role of Biologic TherapyL Puig
Pageof 43